ACT Brief: Bayesian Trials Advance, eSource Integration Scales, and FDA Standards Shift

In today’s ACT Brief, we highlight how Bayesian methods are reshaping adaptive trial design, a major eSource partnership is improving data flow and accuracy, and FDA approval standards continue to evolve.